Determination of the Maximum Tolerated Dose (MTD) of Sea Buckthorn Polysaccharides: Principles, Meth

Determining the maximum tolerated dose (MTD) of sea buckthorn polysaccharides is a fundamental step in the preclinical safety evaluation of this increasingly popular bioactive ingredient. This article outlines the test principles, animal models, dosing protocols, and observation criteria used to establish the MTD of sea buckthorn (Hippophae rhamnoides) polysaccharide extracts in accordance with recognized standards such as GB 15193.3 and OECD Test Guideline 423. The resulting data form an essential part of safety dossiers for health food registration, new food ingredient applications, and nutraceutical product development.

Technical Overview

Sea buckthorn (Hippophae rhamnoides L.) polysaccharides are water-soluble bioactive macromolecules extracted mainly from the berries, seeds, and leaves of the sea buckthorn plant. These polysaccharides, typically composed of neutral sugars and uronic acids with molecular weights ranging from several kilodaltons to several hundred kilodaltons, have been widely studied for immunomodulatory, antioxidant, anti-inflammatory, and gastroprotective activities. As their application in functional foods, dietary supplements, and botanical drug candidates expands, robust acute toxicity data are required to support safe human use.

The maximum tolerated dose (MTD) test is an acute toxicity study designed to identify the highest dose of a test substance that can be administered to experimental animals within a 24-hour period without producing mortality or serious toxicological effects. When the MTD of sea buckthorn polysaccharides exceeds the maximum administrable dose, for example greater than 10 to 15 g/kg body weight, the material is generally classified as practically non-toxic by the acute toxicity classification system. Because high-molecular-weight polysaccharides rarely reach a lethal dose under realistic gavage conditions, the MTD design is more informative and more practical than classical LD50 determinations for this class of compounds.

• Establishes a baseline safety profile prior to repeated-dose and functional studies
• Supports regulatory dossiers requiring acute oral toxicity data
• Confirms the absence of acute hazardous impurities introduced during extraction and purification
• Provides dose-setting reference data for subsequent subchronic and pharmacodynamic studies

Testing Samples

Crude Sea Buckthorn Berry Polysaccharide Extracts

Water-extracted and ethanol-precipitated crude polysaccharide powders are the most common test articles. These typically contain 40 to 80 percent total polysaccharide along with residual proteins, pigments, and minerals. Test articles should be accompanied by documentation of the botanical source, extraction process, total sugar content, uronic acid content, protein content, moisture, and microbial limits.

Purified Polysaccharide Fractions

Column-purified neutral and acidic fractions, including homogeneous fractions characterized by molecular weight distribution and monosaccharide composition, may be submitted for MTD testing during research and development. Purified fractions are particularly relevant when a specific fraction is intended as a functional ingredient or drug candidate.

Formulated Functional Food Products

Finished dosage forms such as capsules, granules, tablets, and oral liquids containing sea buckthorn polysaccharides as the primary functional ingredient may also be evaluated. For finished products, the administered dose is calculated based on the recommended daily human intake multiplied by an appropriate safety factor, and the MTD result supports the margin-of-safety assessment in registration dossiers.

General sample requirements include a minimum quantity of 50 to 200 grams depending on the dosing design, batch number and production date, certificate of analysis, recommended storage conditions, and information on solubility and viscosity, which directly affect the maximum administrable gavage concentration.

Testing Items

The core test item is the acute oral toxicity of the sample, expressed as the MTD in g/kg body weight. The study evaluates the following parameters:

• Mortality and time-to-death within the 14-day observation period
• Clinical signs of toxicity, including coat condition, mucous membrane color, salivation, lacrimation, respiration, locomotor activity, tremors, convulsions, and comatose states
• Body weight changes recorded before dosing, periodically during observation, and at termination
• Food and water consumption trends
• Gross pathological findings at necropsy for all animals, including animals found dead during the study
• Estimation of the LD50 with confidence limits when mortality occurs and dose-response data permit

Testing Methods

Test System and Animal Management

Healthy SPF-grade mice, commonly ICR or KM strains weighing 18 to 22 grams, of both sexes, are used as the standard test system. Animals are group-housed in barrier facilities maintained at 20 to 26 degrees Celsius, 40 to 70 percent relative humidity, and a 12-hour light-dark cycle, with certified rodent diet and drinking water provided ad libitum. A quarantine and acclimation period of at least 3 to 7 days precedes dosing. The study protocol is reviewed and approved by the institutional animal care and ethics committee, and humane endpoints are predefined in accordance with animal welfare requirements.

Dose Preparation and Administration

The test article is prepared in distilled water or an appropriate vehicle at the maximum feasible concentration, limited by solubility and gavage viscosity, and administered by oral gavage at the maximum administrable volume. Following an overnight fast of approximately 12 to 16 hours with free access to water, the animals receive the preparation one to three times within 24 hours at intervals of at least 4 hours. The total daily dose typically reaches 15 to 30 g/kg body weight or the highest technically achievable dose. Limit-test designs consistent with OECD Test Guideline 423 or 425 may be applied when justified.

Observation and Endpoints

Animals are observed continuously for the first 4 to 6 hours after each administration and at least once daily thereafter for 14 days. All abnormal clinical signs, their onset, duration, and resolution are recorded. Body weight is measured before dosing, weekly, and before termination. At the end of the observation period, surviving animals are humanely euthanized and subjected to complete gross necropsy, with examination of major organs and tissues; animals that die during the study are necropsied promptly.

Result Evaluation and Reporting

If no mortality or serious toxicity is observed at the maximum administered dose, the MTD is reported as greater than that total dose, for example MTD greater than 20 g/kg body weight, and the sample is classified as practically non-toxic under the acute toxicity classification of GB 15193.3, corresponding to an LD50 exceeding 5000 mg/kg. If mortality occurs, the study may be extended with additional dose groups to estimate the LD50 and characterize the dose-response relationship. The final report includes the experimental design, animal information, dosing details, all recorded observations, body weight data, necropsy findings, the MTD or LD50 result, and a toxicological conclusion suitable for inclusion in regulatory submissions.

Applications

MTD determination for sea buckthorn polysaccharides serves multiple regulatory, scientific, and commercial purposes:

• Health food and functional food registration dossiers requiring acute toxicity data for the functional ingredient or finished product
• Safety evaluation files for new food raw materials and novel food ingredient applications in various jurisdictions
• Preclinical safety packages supporting botanical drug and traditional medicine development
• Scientific research and peer-reviewed publications characterizing the safety of newly isolated polysaccharide fractions
• Internal quality control and batch safety verification for ingredient manufacturers supplying the nutrition and nutraceutical industries
• Supporting documentation for export compliance and customer audits, often generated in accredited third-party laboratories

FAQ

What is a typical MTD result for sea buckthorn polysaccharides?

Consistent with the general safety profile of plant-derived polysaccharides, most well-manufactured sea buckthorn polysaccharide samples show no mortality or serious adverse effects at the maximum administrable dose, and the MTD is commonly reported as greater than 10 to 20 g/kg body weight, indicating practical non-toxicity. Results can vary with purity, molecular weight, and residual impurities, which is why testing each specific batch or fraction remains necessary.

Why are mice used instead of rats for MTD testing?

Mice are the conventional species for MTD studies in food safety and health food evaluation because their small body weight allows very high dose levels in g/kg terms to be achieved with a limited quantity of test article. Rats may be used as an alternative or confirmatory species when required by the specific regulatory program.

How long does the study take?

The standard study duration includes approximately one week of acclimation followed by dosing and a 14-day observation period, so results are typically available within three to five weeks after sample receipt, depending on laboratory scheduling.

What happens if animals die during the study?

If mortality occurs, the dose level is reduced or additional dose groups are added to determine the dose-response relationship and estimate the LD50. Necropsy findings from deceased animals provide information on the target organs and nature of the acute toxicity, and the material is then classified according to the applicable acute toxicity grading system.

Why must animals be fasted before dosing?

Short-term fasting standardizes gastrointestinal content, which improves the consistency of absorption and reduces variability in the response to a single high oral dose. Water is provided freely during the fasting period, and food is returned shortly after dosing is completed.

Is GLP compliance required for MTD studies?

For exploratory research and internal safety screening, non-GLP studies are generally acceptable. However, when the data are intended for regulatory submission, such as health food registration or new food ingredient approval, the study should be conducted under Good Laboratory Practice conditions in a qualified facility with an approved animal ethics protocol.